Paronychia Its Diagnosis and Current Potential Treatment-based Management: Brief Schematic Review
Published: 2023-11-28
Page: 112-120
Issue: 2023 - Volume 6 [Issue 1]
Yash Srivastav *
Department of Pharmacy, Goel Institute of Pharmacy & Sciences (GIPS), Lucknow, Uttar Pradesh, India.
Nutan Shrivastava
City Women's College, Jankipuram, Lucknow, Uttar Pradesh, India.
Madhaw Kumar
Department of Pharmacy, Goel Institute of Pharmacy & Sciences (GIPS), Lucknow, Uttar Pradesh, India.
*Author to whom correspondence should be addressed.
Abstract
The inflammation of the tissue that immediately surrounds the nail is referred to as paronychia. Paronychia develops when the protective barrier between the nail plate and the neighbouring nail fold is disrupted, either by infectious or noninfectious reasons. It is possible for paronychia to be an acute or chronic illness. Acute paronychia is typically brought on by bacterial infections and results from the skin's decreased ability to protect itself. Pemphigus vulgaris, fungus, viruses, and trauma (finger sucking) are some more motives. Comparatively speaking to acute paronychia, chronic paronychia is multifactorial. Patients who have diabetes, psoriasis, maceration, or have been exposed to irritants or injuries that either compromise the integrity of the epidermal barrier or reduce local resistance are more likely to report this syndrome. The pathogenesis, aetiology, medical treatment, and diagnosis of paronychia are all covered in this review article.
Keywords: Paronychia, history, etiology, pathophysiology, diagnosis, management
How to Cite
Downloads
References
Sawarkar P, Sawarkar G. Contribution of Ayurveda for management of paronychia: A case report. J Indian Syst Med. 2019;7(4):240.
Hochman LG. Paronychia: More Than Just an Abscess. Int J Dermatol. 1995;34(6):385–6.
Rigopoulos D, Larios G, Gregoriou S, Alevizos A. Acute and chronic paronychia. Am Fam Physician. 2008;77(3).
Rockwell PG. Acute and chronic paronychia. Am Fam Physician. 2001; 63(6):1113–6.
Caitlyn M. Rerucha M. Acute Hand Infections. Am Acad Fam Physicians. 2019;99(4):228–36.
Sampson B, Lewis BKH. Paronychia associated with ledipasvir/sofosbuvir for hepatitis C treatment. J Clin Aesthet Dermatol. 2019;12(1):35–7.
Moran TE, Freilich AM. Hand Infection [Internet]. StatPearls Publishing, Treasure Island (FL); 2022. Available:http://europepmc.org/books/NBK557849
Daniel CR III. Paronychia. In: Greer KE, ed. Common problems in dermatology. Chicago: Year Book, 1988;1988: 249-255.
Daniel CR III. Nonfungal infections. In: Scher RK, Daniel CR III, eds. Nails: therapy, diagnosis, surgery. Philadelphia: WB Saunders. 1990;1990:122-124.
Relhan V, Bansal A. Acute and chronic paronychia revisited: A narrative review. J Cutan Aesthet Surg. 2022;15(1):1–16.
Biesbroeck LK, Fleckman P. Nail disease for the primary care provider. Med Clin North Am 2015;99:1213-26.
Brook I. Paronychia: a mixed infection. Microbiology and management. J Hand Surg Br 1993;18:358-9.
Rigopoulos D, Larios G, Gregoriou S, Alevizos A. Acute and chronic paronychia. Am Fam Physician 2008;77:339-46.
Shafritz AB, Coppage JM. Acute and chronic paronychia of the hand. J Am Acad Orthop Surg 2014;22:165-74.
Studies on Experimental Chronic Paronychia; 2015.
Zais N. The nail in health and disease. Norwalk, CT: Appleton and Lange. 1990;131:222-223.
Tosti A, Guerra L, Morelli R, Bardazzi F, Fanti PA. Role of foods in the pathogenesis of chronic paronychia. J Am Acad Dermatol. 1992;27(5):706–10.
Relhan V, Goel K, Bansal S, Garg VK. Management of chronic paronychia. Indian J Dermatol. 2014 Jan;59(1):15–20.
Rubin AI, Ralph Daniel C. Acute and chronic paronychia. Scher Daniel’s Nails Diagnosis, Surgery, Ther Fourth Ed. 2018; 215–25.
Hay RJ, Baran R, Moore MK, Wilkinson JD. Candida onychomycosis—an evaluation of the role of Candida species in nail disease. Br J Dermatol. 1988; 118(1): 47–58.
Bednar MS, Lane LB. Eponychial marsupialization and nail removal for surgical treatment of chronic paronychia. J Hand Surg Am [Internet]. 1991;16(2):314–7. Available:http://dx.doi.org/10.1016/S0363-5023(10)80118-2
Tosti A, Piraccini BM, Ghetti E, Colombo MD. Topical steroids versus systemic antifungals in the treatment of chronic paronychia: An open, randomized double-blind and double dummy study. J Am Acad Dermatol. 2002;47(1):73–6.
Garden BC, Wu S, Lacouture ME. The risk of nail changes with epidermal growth factor receptor inhibitors: a systematic review of the literature and meta- analysis. 2012. In: Database of Abstracts of Reviews of Effects (DARE): Quality-assessed Reviews [Int. 2012;66:37–9.
Goto H, Yoshikawa S, Mori K, Otsuka M, Omodaka T, Yoshimi K, et al. Effective treatments for paronychia caused by oncology pharmacotherapy. J Dermatol. 2016;43(6):670–3.
Kapellen TM, Galler A, Kiess W. Higher frequency of paronychia (nail bed infections) in pediatric and adolescent patients with type 1 diabetes mellitus than in non-diabetic peers. J Pediatr Endocrinol Metab. 2003;16(5):751–8.
Dulski A, Edwards CW. Paronychia. [Updated 2023 Aug 7]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan. Available:https://www.ncbi.nlm.nih.gov/books/NBK544307/. 2023;544307.
Nakano J, Nakamura M. Paronychia induced by gefitinib, an epidermal growth factor receptor tyrosine kinase inhibitor [5]. J Dermatol. 2003;30(3):261–2.
Relhan, Vineet, et al. Management of chronic paronychia. Indian Journal of Dermatology 59.1 (2014): 15. 2014;1: 2014.
Duhard É. [Paronychia]. Presse Med 2014; 43:1216- 1222.
PMID: 25441843.
Bahunuthula, Rakesh Kumar, et al. Evaluation of role of Candida in patients with chronic paronychia. Indian Journal of Dermatology, Venereology and Leprology 81 (2015): 485. 2015;81:2015.
Colson AE, Sax PE, Keller MJ, Turk BK, Pettus PT, Platt R, et al. Paronychia in association with indinavir treatment. Clin Infect Dis. 2001;32(1):140–3.
Natsis NE, Cohen PR. Coagulase-Negative Staphylococcus Skin and Soft Tissue Infections. Am J Clin Dermatol [Internet]. 2018;19(5):671–7. Available:https://doi.org/10.1007/s40257-018-0362-9
Brook I. The role of anaerobic bacteria in cutaneous and soft tissue abscesses and infected cysts. Anaerobe. 2007;13(5–6): 171–7.
Harries E. Chronic Paronychia. Br Med J. 1975;3(5974):45.
Lomax A, Thornton J, Singh D. Toenail paronych ia. Foot Ankle Surg 2016; 22: 219-223. PMID: 27810017.
Daniel CR 3rd, Iorizzo M, Piraccini BM, Tosti A. Grading simple chronic paronychia and onycholysis. Int J Dermatol 2006;45: 1447-1448. PMID:17184257. 2006;17184257.
Turkmen A, Warner RM, Page RE. Digital pressure test for paronychia [2]. Br J Plast Surg. 2004;57(1):93–4.
Aluja Jaramillo F, Quiasúa Mejía DC, Martínez Ordúz HM, González Ardila C. Nail unit ultrasound: a complete guide of the nail diseases. J Ultrasound. 2017; 20(3): 181–92.
Raff AB, Kroshinsky D. Cellulitis a review. JAMA - J Am Med Assoc. 2016;316(3): 325–37.
Patel DB, Emmanuel NB, Stevanovic M V., Matcuk GR, Gottsegen CJ, Forrester DM, et al. Hand infections: Anatomy, types and spread of infection, imaging findings, and treatment options. Radiographics. 2014; 34(7):1968–86.
Pierrart J, Delgrande D, Mamane W, Tordjman D, Masmejean EH. Acute felon and paronychia: Antibiotics not necessary after surgical treatment. Prospective study of 46 patients. Hand Surg Rehabil [Internet]. 2016;35(1):40–3. Available:http://dx.doi.org/10.1016/j.hansur.2015.12.003
Grover C, Bansal S, Nanda S, Reddy BSN, Kumar V. En bloc excision of proximal nail fold for treatment of chronic paronychia. Dermatologic Surg. 2006;32(3):393–9.
Shafritz AB, Coppage JM. Acute and chronic paronychia of the hand. J Am Acad Orthop Surg. 2014;22(3):165–74.
Carley SD. Towards evidence based emergency medicine: Best BETs from the Manchester Royal Infirmary. Emerg Med J. 2005;22(11):813.
Pabari A, Iyer S, Khoo CT. Swiss roll technique for treatment of paronychia. Tech Hand Up Extrem Surg. 2011; 15(2):75–7.